Hepatitis B Workup: Approach Considerations, Diagnostic Tests, Radiologic Studies
Diagnostics of Hepatitis B Virus: Standard of Care and Investigational - Jackson - 2018 - Clinical Liver Disease - Wiley Online Library
Viral Hepatitis Surveillance and Case Management - Hepatitis A | CDC
Hepatitis C | Cleveland Clinic
Hepatitis B virus precore mutant - Wikipedia
Screening for Viral Hepatitis During the Domestic Medical Examination of Newly Arrived Refugees | Immigrant and Refugee Health | CDC
Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis | Gut Pathogens | Full Text
Screening for Viral Hepatitis During the Domestic Medical Examination of Newly Arrived Refugees | Immigrant and Refugee Health | CDC
Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group - Journal of Hepatology
Hepatitis B: Practice Essentials, Background, Pathophysiology
Safety and antiviral activity of VIR-2218, an X-targeting RNAi therapeutic, in participants with chronic hepatitis B infection: week 48 follow-up results HBV Functional Cure Candidate, an siRNA, Passes Phase 2 Test of
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - Journal of Hepatology
Therapeutic strategies for hepatitis B virus infection: towards a cure | Nature Reviews Drug Discovery
Journal of Viral Hepatitis - Wiley Online Library
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan | Scientific Reports
Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination - Czaja - 2020 - Clinical Liver Disease - Wiley Online Library
Journal of Viral Hepatitis - Wiley Online Library
Safety and antiviral activity of VIR-2218, an X-targeting RNAi therapeutic, in participants with chronic hepatitis B infection: week 48 follow-up results HBV Functional Cure Candidate, an siRNA, Passes Phase 2 Test of
Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group - Journal of Hepatology
Structural insights into hepatitis C virus receptor binding and entry | Nature
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside - Gastroenterology
